12/10/2024
7:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024
7:37 AM | ImmunoPrecise Antibodies (Filer)
| Form 20-F/A | |
12/10/2024
7:33 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024
7:33 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024
8:17 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
7:54 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024
6:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
10/21/2024
8:08 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
2:25 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024
8:39 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024
7:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024
8:13 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
1:40 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
8:04 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024
8:41 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024
7:01 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024
8:21 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2024
11:15 PM | ImmunoPrecise Antibodies (Filer)
| Form EFFECT | |
08/06/2024
4:16 PM | ImmunoPrecise Antibodies (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
07/30/2024
12:57 PM | ImmunoPrecise Antibodies (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/29/2024
7:35 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024
7:38 AM | ImmunoPrecise Antibodies (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
07/23/2024
8:55 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2024
8:41 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
7:32 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
8:12 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2024
12:01 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/10/2024
1:23 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
12:21 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
11:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
7:21 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
7:00 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
10:19 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/27/2024
9:33 AM | ImmunoPrecise Antibodies (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G | |
02/23/2024
4:26 PM | ImmunoPrecise Antibodies (Filer)
| Form 424B5 | |
02/23/2024
4:29 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2024
2:12 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K/A | |
01/10/2024
12:53 PM | Charmquark TWEE (Filed by)
ImmunoPrecise Antibodies (Subject)
| Form SC 13G/A | |
01/10/2024
12:33 PM | Charmquark TWEE (Filed by)
ImmunoPrecise Antibodies (Subject)
| Form SC 13G | |
The #1 Coin for November 2024 (Ad) Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin…
And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone!
I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
 You can get access to the report by clicking here now… |
